proof-of-concept studies for these therapeutics remain the main hurdle. Tufts Center for the Study of Drug Development (Boston) has previously reported on trends in the clinical development of ...

Patheon, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced plans ...